EX-99.1 2 eh220299528_ex9901.htm EXHIBIT 99.1

EXHIBIT 99.1

 

RXO

Reconciliation of Net Income to Adjusted EBITDA and Public Company Pro Forma Adjusted EBITDA

(Unaudited)

(In millions)

 

   Three Months Ended 
   March 31,
2020
   June 30,
2020
  

September 30,

2020

  

December 31,

2020

   March 31,
2021
   June 30,
2021
  

September 30,

2021

  

December 31,

2021

   March 31,
2022
   June 30,
2022
 
Net income (loss)  $(2)  $(16)  $23   $38   $40   $35   $33   $42   $39   $44 
Interest expense                                        
Income tax provision (benefit)       (5)   8    11    10    13    5    13    12    15 
Depreciation and amortization expense   17    18    20    21    20    20    22    19    21    21 
Transaction and integration costs   5    7        2    1        1        3    18 
Restructuring costs   2    7        1            1    1        3 
Other                       (1)       2         
Adjusted EBITDA (1)   $22   $11   $51   $73   $71   $67   $62   $77   $75   $101 
Reversal of allocated corporate expense (2) and other   2    9    2    3    8    4    5    12    9    6 
Public company standalone cost (3)   (11)   (12)   (11)   (11)   (11)   (12)   (11)   (11)   (11)   (12)
Public company pro forma adjusted EBITDA (1)  $13   $8   $42   $65   $68   $59   $56   $78   $73   $95 

 

 

(1)See the "Non-GAAP Financial Measures" section for additional information.
(2)Allocated corporate expense per RXO Form 10 combined financial statements; excludes the impact of adjusted items and allocated income tax, depreciation and amortization from XPO Corporate.
(3)Estimated incremental costs of operating RXO as a standalone public company.

 

 

 

 

 

RXO

Revenue Disaggregated by Service Offering

(Unaudited)

(In millions)

 

   Three Months Ended 
   March 31,
2020
   June 30,
2020
  

September 30,

2020

  

December 31,

2020

   March 31,
2021
   June 30,
2021
  

September 30,

2021

  

December 31,

2021

   March 31,
2022
   June 30,
2022
 
Revenue                                        
Truck brokerage  $328   $302   $432   $622   $596   $607   $700   $846   $824   $755 
Last mile   200    219    243    246    246    269    250    251    246    274 
Managed transportation   142    119    153    168    167    167    151    118    139    133 
Freight forwarding   43    60    57    65    75    89    125    145    139    100 
Eliminations   (11)   (16)   (8)   (7)   (19)   (33)   (28)   (33)   (36)   (36)
Total  $702   $684   $877   $1,094   $1,065   $1,099   $1,198   $1,327   $1,312   $1,226 

 

 

 

 

 

Non-GAAP Financial Measures

 

This document contains the following non-GAAP financial measures for RXO: adjusted earnings before interest, taxes, depreciation and amortization, as further adjusted in connection with the contemplated spin-off transaction (“adjusted EBITDA”); and public company pro forma adjusted EBITDA.

 

We believe that the above adjusted financial measures facilitate analysis of the ongoing business operations of RXO because they exclude items that may not be reflective of, or are unrelated to, RXO’s business’ core operating performance, and may assist investors with comparisons to prior periods and assessing trends in our underlying businesses. Other companies may calculate these non-GAAP financial measures differently, and therefore our measures may not be comparable to similarly titled measures of other companies. These non-GAAP financial measures should only be used as supplemental measures of our operating performance.

 

Adjusted EBITDA includes adjustments for transaction and integration costs as well as restructuring costs. Transaction and integration adjustments are generally incremental costs that result from an actual or planned acquisition, divestiture or spin-off and may include transaction costs, consulting fees, retention awards, and internal salaries and wages (to the extent the individuals are assigned full-time to integration and transformation activities) and certain costs related to integrating and converging IT systems. Restructuring costs primarily relate to severance costs associated with business optimization initiatives. Management uses this non-GAAP financial measure in making financial, operating and planning decisions and evaluating RXO’s ongoing performance. Public company pro forma adjusted EBITDA includes adjustments for the reversal of allocated corporate expenses, public company operating expense and expense of being a public company.

 

We believe that adjusted EBITDA and public company pro forma adjusted EBITDA improve comparability from period to period by removing the impact of RXO’s capital structure (interest and financing expenses), asset base (depreciation and amortization), tax impacts and other adjustments as set out in the attached tables that management has determined are not reflective of core operating activities and thereby assist investors with assessing trends in RXO’s underlying businesses.